Global Aesthetic Injectables Market Insights Forecasts to 2030
- The Global Aesthetic Injectables Market Size was valued at USD 15.7 Billion in 2021
- The Worldwide Market Share is Growing at a CAGR of 9.34% from 2022 to 2030
- The Worldwide Aesthetic Injectables Market Size is expected to reach USD 37.5 Billion by 2030
- Asia Pacific is expected to Grow the fastest during the forecast period
Get more details on this report -
The Global Aesthetic Injectables Market Size is expected to reach USD 37.5 Billion by 2030, at a CAGR of 9.34% during the forecast period 2022 to 2030.
Within the past decade, it has been increasingly clear that success with cosmetic injectables can be an amazing way to experience many of the benefits of cosmetic surgery without the drawbacks. The injection previously utilized in the early stage was almost often intralesional steroids used to treat cystic acne. Aesthetic operations can now improve the structure and volume of your face and lips, as well as soften wrinkles and contour your body, by using injectable therapy. Fillers, toxins, platelet-rich plasma, stem cells, fat-breaking agents, and tranexamic acid are only a few of the compounds injected into the skin.
Consumers are becoming more aware of and accepting of aesthetics as their ideas about health, beauty, and good aging evolve. As a result, demand from new patient groups such as men and Generation Y has surged. In most distribution channels, the primary targeted market for cosmetic injectables is privileged women over 40 considering facial procedures. On average, those with annual earnings of more than $100,000 are the most active users worldwide. Furthermore, while men continue to constitute a minority of consumers in most markets, the proportion of men who utilize aesthetic treatments is increasing, particularly in Europe and North America, as well as among affluent social groups.
This research report categorizes the market for Global Aesthetic Injectables Market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Global Aesthetic Injectables Market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segments of the Global Aesthetic Injectables Market.
Global Aesthetic Injectables Market Report Coverage
|Market Size in 2021:||USD 15.7 Billion|
|Forecast Period 2021-2030 CAGR:||9.34%|
|2030 Value Projection:||USD 37.5 Billion|
|Historical Data for:||2017-2020|
|No. of Pages:||200|
|Tables, Charts & Figures:||100|
|Segments covered:||By Type, By Application, By End User, By Region, COVID-19 Impact Analysis|
|Companies Covered:||USWM, LLC, Revance Therapeutics, Inc., Sinclair Pharma, Bioxis Pharmaceuticals, Allergan (AbbVie, Inc.), Merz Pharma, BIOPLUS CO., LTD., Anika Therapeutics, Inc., Ipsen Pharma, GALDERMA, Prollenium Medical Technologies, Nestle Skin Health, SciVision Biotech Inc., Bloomage BioTechnology Corporation Ltd., Suneva Medical, Inc., Teoxane SA, Huadong Medicine Co Ltd., Zimmer Biomet Pharmaceuticals, Medytox Inc.|
|Pitfalls & Challenges:||COVID-19 Empact, Challenge, Future, Growth, & Analysis|
Get more details on this report -
Aesthetic procedures are becoming more widely available all around the world. Consolidation and expansion are two opposed forces pulling in opposite directions. Social media is raising patient awareness and acceptance, particularly among newly diagnosed patients. Social media coverage of neuromodulators surged fivefold over the decade, whereas dermal fillers and bio-stimulators increased eightfold. Men and people under the age of 25 accounts for 60% of Twitter mention, demonstrating that digital marketing has a large impact on new patient groups.
Next-generation advancements, such as bio-stimulators and silk-based technologies, are also emerging. According to the survey, healthcare professionals are interested in employing such technologies in the next years. Furthermore, the general demand for filler treatments has risen considerably over the years, driven mostly by the desire for a greater aesthetic appearance and the development of novel fillers. As a result of these favorable changes, the aesthetic injectables market is predicted to rise rapidly.
The COVID-19 pandemic had a negative impact on the aesthetics injectables market, causing the closure of cosmetic and dermatological clinics worldwide. As a result, because these operations are deemed non-essential, they were among the first in the healthcare sector to experience major limits and cancellations.
- In 2021, the hyaluronic acid segment dominated the market with the largest share over the forecast period
Based on type, the Global Aesthetic Injectables Market is segmented into collagen, hyaluronic acid, botulinum toxin, polylactic acid, polymethyl-methacrylate microspheres, calcium hydroxylapatite, fat injections, and others. Among them, the hyaluronic acid segment dominated the market with the biggest share owing to the widespread application of these fillers and their widespread adoption. Hyaluronic acid offers numerous advantages, including increased hydration, improved flexibility, and the ability to repair free radical damage whilst guarding against Uv exposure. The significant increase in female cancer instances is likely to raise demand for effective health gadgets, driving the segment's expansion over the forecasted period.
- In 2021, the wrinkle reduction segment is witnessing significant CAGR growth over the forecast period
On the basis of applications, the Global Aesthetic Injectables Market is segmented into a facelift, facial line correction, acne scar treatment, wrinkle reduction, lip enhancement, lipoatrophy treatment, and others. Among these, the regenerative segment is witnessing significant CAGR growth over the forecast period. The category's growth is due to strong product releases in these segments, as well as various investment attempts to produce unique items in this area. The increased interest in physical appearance, combined with an increase in disposable wealth among developing country middle-class populations, is likely to drive the requirement for aesthetic injectables in the future years.
- In 2021, the dermatology & cosmetic clinics segment is dominating the market with the largest market share of 45% over the forecast period
Based on end user, the Global Aesthetic Injectables Market is segmented into hospitals & ambulatory surgery centers, dermatology & cosmetic clinics, and others. Among these, the dermatology & cosmetic clinics segment dominates the market with the largest market share of 45% over the forecast period. This segments dominance is due to the high volume of injectable facial procedures performed in dermatology and cosmetic clinics. Furthermore, because these treatments need little to no recovery time, many people choose to have these fillers placed in these areas.
Regional Segment Analysis of the Global Aesthetic Injectables Market
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Rest of APAC)
- South America (Brazil and the Rest of South America)
- The Middle East and Africa (UAE, South Africa, Rest of MEA)
North America is dominating the market with the largest market share of 54%.
Get more details on this report -
North America is expected to remain the industry's leading region during the forecast period, with a 54% market share, owing to aspects like raising awareness of aesthetic surgical procedures, technological advancements in cosmetic procedures, the presence of major market participants, and an aging population. Because of the emergence of new treatment options such as numerous aesthetics clinic chains and wellness and beauty bars that specialize in cosmetic micro treatments, patients in the United States now have better access to injectables. The growing focus on aging aesthetics within this age group is likely to drive demand for aesthetic fillers, fueling the market during the forecast period in the North American region.
Asia Pacific is expected to grow the fastest during the forecast period. China, India, Australia, and South Korea are among the developing countries that support the aesthetics injectables market growth in the Asia Pacific region. Private aesthetics clinic chains are quickly increasing in China, with large digital platforms providing first-time access to patients in primarily underdeveloped third and fourth-tier cities.
The report offers the appropriate analysis of the key organizations/companies involved within the Global Aesthetic Injectables Market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Market Top Players
- USWM, LLC
- Revance Therapeutics, Inc.
- Sinclair Pharma
- Bioxis Pharmaceuticals
- Allergan (AbbVie, Inc.)
- Merz Pharma
- BIOPLUS CO., LTD.
- Anika Therapeutics, Inc.
- Ipsen Pharma
- Prollenium Medical Technologies
- Nestle Skin Health
- SciVision Biotech Inc.
- Bloomage BioTechnology Corporation Ltd.
- Suneva Medical, Inc.
- Teoxane SA
- Huadong Medicine Co Ltd.
- Zimmer Biomet Pharmaceuticals
- Medytox Inc.
Key Target Audience
- Market Players
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
- In October 2022, Galderma confirmed the continuation of its collaboration with the National Breast Cancer Foundation Inc. Galderma is highlighting the personal tales and treatment journeys of breast cancer survivors who received products from Galderma's Aesthetic portfolio, including Restylane®, Dysport®* (abobotulinumtoxinA), and/or Sculptra®.
- In August 2022, Allergan Healthcare India Private Limited announced the launch of Juvéderm Volux in India through its Allergan Aesthetics Business Unit. Juvéderm Volux is an injectable implant that contains hyaluronic acid 25 mg and lidocaine hydrochloride 3 mg. It is meant to repair and create volume in the face.
This study forecasts revenue at global, regional, and country levels from 2021 to 2030. Spherical Insights has segmented the Global Aesthetic Injectables Market based on the below mentioned segments:
Global Aesthetic Injectables Market, By Type
- Hyaluronic Acid
- Botulinum Toxin
- Polylactic Acid
- Polymethyl-methacrylate Microspheres (PMMA)
- Calcium Hydroxylapatite
- Fat Injections
Global Aesthetic Injectables Market, By Application
- Facial Line Correction
- Acne Scar Treatment
- Wrinkle Reduction
- Lip Enhancement
- Lipoatrophy Treatment
Global Aesthetic Injectables Market, By End User
- Hospitals & Ambulatory Surgery Centers
- Dermatology & Cosmetic Clinics
Global Aesthetic Injectables Market, Regional Analysis
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- South America
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
Need help to buy this report?